YCM
PKBO

Yakira Capital Management’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Yakira Capital Management’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$499K – 439
2022
Q3 		$499K Hold
50,000
– – 0.07% 202
2022
Q2 		$493K Buy
+50,000
New +$493K 0.08% 208

Other funds holding PKBO

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Yakira Capital Management's PKBO Position: Q4 2022 in Review

Yakira Capital Management sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 50,000 shares — an estimated $499K sold.

Yakira Capital Management first reported a position in PKBO in Q2 2022 and held it in 2 quarters. The position peaked at $499K in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

  • Yakira Capital Management reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Yakira Capital Management sold 50,000 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $499K.
  • Yakira Capital Management first reported a position in Peak Bio, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Yakira Capital Management's Peak Bio, Inc. Common Stock position peaked at $499K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Yakira Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.